Friday, June 19, 2026

Iran’s World Cup Participation: Is It Possible Amidst Tensions with the U.S.?

Iran's Minister of Sports declares the national soccer team's participation in the North American World Cup impossible due to U.S. tensions.

What Is PCOS? The Common Hormone Disorder Many Women Don’t Know They Have

PCOS affects 6-15% of women, causing ovulation issues and metabolic risks. Early diagnosis and lifestyle changes are vital for management.

THE BOYZ Release Second Full-length Album [Phantasy] Pt.3 Love Letter

Male K-POP group THE BOYZ is...

Tag: Nesuparib

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Next-Gen Cancer Drug Nesuparib: How It Outperforms Olaparib in SCLC and Pancreatic Cancer

Onconic Therapeutics will present Nesuparib research at AACR 2026, showcasing its potential for various cancers and overcoming PARP inhibitor limitations.

Nesuparib: A Game-Changer in Cancer Treatment? Key Findings from AACR 2026

Onconic Therapeutics' Nesuparib shows promising results against small cell lung and pancreatic cancers, highlighting its competitive edge.

Nesuparib vs. Traditional Treatments: Will This New Dual-Target Cancer Drug Change the Game for Ovarian Cancer?

Onconic Therapeutics advances Nesuparib into Phase 2 trials for ovarian cancer, aiming to validate a novel re-maintenance therapy approach.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.